Inhibitor Therapeutics, Inc. (CBTE) .
本页证实的标准:
SharesGrow 综合评分： 40/100 其中 1/7 项标准通过。
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2010 | $0.00 | $3.17B | $0.00 | 0% |
| 2011 | $-0.02 | $982.1M | $-227.89M | -23.2% |
| 2012 | $0.00 | $560.67M | $0.00 | 0% |
| 2013 | $-0.10 | $166.68M | $-1.84M | -1.1% |
| 2014 | $-0.04 | $1.51B | $-3.98M | -0.3% |
| 2015 | $-0.02 | $2.27B | $-3.95M | -0.2% |
| 2016 | $-0.02 | $4.38B | $-7M | -0.2% |
| 2017 | $-0.01 | $2.89B | $-5.1M | -0.2% |
| 2018 | $-0.01 | $1.93B | $-4.55M | -0.2% |
| 2019 | $-0.01 | $14.54K | $-2.73M | -18798.9% |
